Buy Inlyta Generic (axitinib) – International Cost

$88.00 USD$149.00 USD

Bdaxit™ is a quality assured generic of Inlyta® used as first-line treatment of patients with advanced renal cell carcinoma (RCC) in combination with other medicines. It’s also indicated for the treatment of advanced renal cell carcinoma (RCC) in adult patients who failed 1 prior systemic therapy. It’s produced in a WHO & EMA approved factory in India.

Package Size : 28 Tablets

Active Ingredients : Axitinib 1 MG, 5 MG

Produced by BDR Pharmaceuticals Ltd®

SKU: 27385 Category: Tags: , ,